Full Breakdown
AstroRad Vest Tested on Artemis I Shows Promise for Reducing Solar Radiation Exposure
8/13/2026, 12:01:26 AM
Core Event: Vest Tested on Uncrewed Artemis I Mission
During NASA’s uncrewed Artemis I flight around the Moon in late 2022, researchers flew two anatomically realistic female torso “phantoms.” The Zohar phantom wore the AstroRad radiation-shielding vest, while the Helga phantom had no protection. Both were instrumented with thousands of radiation sensors and traversed the inner Van Allen belt, allowing the team to compare dose measurements and model vest performance during historic solar particle events.
Background & Context
Solar particle events (SPEs) eject high-energy protons that can dramatically increase an astronaut’s radiation dose, raising the lifetime risk of cancer. Earth’s magnetic field blocks most of this radiation, but spacecraft and deep-space habitats lack such protection. Traditional shielding (e.g., lead) is too heavy for spaceflight, prompting the development of targeted, lightweight garments. The Artemis program, which seeks to return humans to the Moon and eventually send crews to Mars, requires countermeasures to keep cumulative exposure below NASA’s career limit of 600 mSv.
Data & Statistics
- Vest mass: ? 57 lb (26 kg).
- Dose reduction (1972 SPE): from 222 mSv to 87.5 mSv – about a 60 % decrease.
- Dose reduction (1989 SPE): roughly 40 % decrease.
- Typical Earth background: ? 3 mSv per year.
- Potential exposure spared: up to 193 days of deep-space radiation.
Official Statements & Responses
Jordan Houri, lead scientist for space exploration at StemRad, explained that AstroRad is intended as an emergency countermeasure: astronauts would don the vest only when radiation levels rise, for periods of hours to days, rather than continuously. He noted that the vest’s targeted shielding—focused on radiation-sensitive organs such as bone marrow, lungs, gastrointestinal tract, breasts, and ovaries—delivers about 30 % more dose reduction than an equivalent amount of uniform shielding.
Oren Milstein, CEO and co-founder of StemRad, emphasized that the vest’s plastic, hydrogen-rich composition avoids the secondary radiation problems associated with lead, making it lighter and more practical for space travel. He highlighted that women, whose reproductive organs are especially vulnerable, stand to benefit from the organ-specific protection.
The team is now pursuing a modular design that can be tailored to different body shapes, reducing launch mass and allowing a single baseline vest to serve multiple crew members during a solar storm.
Why It Matters
By cutting radiation dose during SPEs, the AstroRad vest could enable astronauts to undertake longer-duration lunar or Martian missions without exceeding the 600 mSv career limit. The ability to work outside the spacecraft’s storm shelter while remaining protected expands operational flexibility and mission productivity.
Verbatim Quotes
- “The amount of dose reduction that we saw was surprising,” — Jordan Houri
- “Women are predicted to face a higher risk of radiation-induced cancer,” — Oren Milstein
- “The most important implication is that AstroRad could help overcome one of the major health challenges limiting long-duration human exploration beyond Earth ,” — Oren Milstein
What's Next
Developers plan to finalize a modular vest system that can be quickly reconfigured for individual crew members, further lowering launch weight. Future testing will assess integration with spacecraft storm shelters and evaluate long-term wearability on the International Space Station, paving the way for deployment on upcoming Artemis crewed flights.
